BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 27553833)

  • 21. MicroRNA-375 inhibits colorectal cancer growth by targeting PIK3CA.
    Wang Y; Tang Q; Li M; Jiang S; Wang X
    Biochem Biophys Res Commun; 2014 Feb; 444(2):199-204. PubMed ID: 24440701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. microRNA-202-3p inhibits cell proliferation by targeting ADP-ribosylation factor-like 5A in human colorectal carcinoma.
    Wang Q; Huang Z; Guo W; Ni S; Xiao X; Wang L; Huang D; Tan C; Xu Q; Zha R; Zhang J; Sheng W; He X; Du X
    Clin Cancer Res; 2014 Mar; 20(5):1146-57. PubMed ID: 24327274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miRNA profiling in colorectal cancer highlights miR-1 involvement in MET-dependent proliferation.
    Reid JF; Sokolova V; Zoni E; Lampis A; Pizzamiglio S; Bertan C; Zanutto S; Perrone F; Camerini T; Gallino G; Verderio P; Leo E; Pilotti S; Gariboldi M; Pierotti MA
    Mol Cancer Res; 2012 Apr; 10(4):504-15. PubMed ID: 22343615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ERK Activation Globally Downregulates miRNAs through Phosphorylating Exportin-5.
    Sun HL; Cui R; Zhou J; Teng KY; Hsiao YH; Nakanishi K; Fassan M; Luo Z; Shi G; Tili E; Kutay H; Lovat F; Vicentini C; Huang HL; Wang SW; Kim T; Zanesi N; Jeon YJ; Lee TJ; Guh JH; Hung MC; Ghoshal K; Teng CM; Peng Y; Croce CM
    Cancer Cell; 2016 Nov; 30(5):723-736. PubMed ID: 27846390
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-320 suppresses colorectal cancer by targeting SOX4, FOXM1, and FOXQ1.
    Vishnubalaji R; Hamam R; Yue S; Al-Obeed O; Kassem M; Liu FF; Aldahmash A; Alajez NM
    Oncotarget; 2016 Jun; 7(24):35789-35802. PubMed ID: 27119506
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-124 reduces the pentose phosphate pathway and proliferation by targeting PRPS1 and RPIA mRNAs in human colorectal cancer cells.
    Qiu Z; Guo W; Wang Q; Chen Z; Huang S; Zhao F; Yao M; Zhao Y; He X
    Gastroenterology; 2015 Nov; 149(6):1587-1598.e11. PubMed ID: 26248089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The deoxycholic acid targets miRNA-dependent CAC1 gene expression in multidrug resistance of human colorectal cancer.
    Kong Y; Bai PS; Sun H; Nan KJ; Chen NZ; Qi XG
    Int J Biochem Cell Biol; 2012 Dec; 44(12):2321-32. PubMed ID: 22903020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis.
    Zhang N; Li X; Wu CW; Dong Y; Cai M; Mok MT; Wang H; Chen J; Ng SS; Chen M; Sung JJ; Yu J
    Oncogene; 2013 Oct; 32(42):5078-88. PubMed ID: 23208495
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel Evidence for Curcumin and Boswellic Acid-Induced Chemoprevention through Regulation of miR-34a and miR-27a in Colorectal Cancer.
    Toden S; Okugawa Y; Buhrmann C; Nattamai D; Anguiano E; Baldwin N; Shakibaei M; Boland CR; Goel A
    Cancer Prev Res (Phila); 2015 May; 8(5):431-43. PubMed ID: 25712055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA Biogenesis Pathway Genes Are Deregulated in Colorectal Cancer.
    Vychytilova-Faltejskova P; Svobodova Kovarikova A; Grolich T; Prochazka V; Slaba K; Machackova T; Halamkova J; Svoboda M; Kala Z; Kiss I; Slaby O
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31510013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Upregulation of miR-199a/b contributes to cisplatin resistance via Wnt/β-catenin-ABCG2 signaling pathway in ALDHA1
    Chen B; Zhang D; Kuai J; Cheng M; Fang X; Li G
    Tumour Biol; 2017 Jun; 39(6):1010428317715155. PubMed ID: 28639895
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 3'-UTR Polymorphisms in the MiRNA Machinery Genes DROSHA, DICER1, RAN, and XPO5 Are Associated with Colorectal Cancer Risk in a Korean Population.
    Cho SH; Ko JJ; Kim JO; Jeon YJ; Yoo JK; Oh J; Oh D; Kim JW; Kim NK
    PLoS One; 2015; 10(7):e0131125. PubMed ID: 26147304
    [TBL] [Abstract][Full Text] [Related]  

  • 33. microRNA-224 promotes cell proliferation and tumor growth in human colorectal cancer by repressing PHLPP1 and PHLPP2.
    Liao WT; Li TT; Wang ZG; Wang SY; He MR; Ye YP; Qi L; Cui YM; Wu P; Jiao HL; Zhang C; Xie YJ; Wang JX; Ding YQ
    Clin Cancer Res; 2013 Sep; 19(17):4662-72. PubMed ID: 23846336
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disruption of microRNA nuclear transport in human cancer.
    Melo SA; Esteller M
    Semin Cancer Biol; 2014 Aug; 27():46-51. PubMed ID: 24607282
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of colorectal cancer stem cell survival and invasive potential by hsa-miR-140-5p mediated suppression of Smad2 and autophagy.
    Zhai H; Fesler A; Ba Y; Wu S; Ju J
    Oncotarget; 2015 Aug; 6(23):19735-46. PubMed ID: 25980495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Global microRNA elevation by inducible Exportin 5 regulates cell cycle entry.
    Iwasaki YW; Kiga K; Kayo H; Fukuda-Yuzawa Y; Weise J; Inada T; Tomita M; Ishihama Y; Fukao T
    RNA; 2013 Apr; 19(4):490-7. PubMed ID: 23431327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor suppressor functions of miR-133a in colorectal cancer.
    Dong Y; Zhao J; Wu CW; Zhang L; Liu X; Kang W; Leung WW; Zhang N; Chan FK; Sung JJ; Ng SS; Yu J
    Mol Cancer Res; 2013 Sep; 11(9):1051-60. PubMed ID: 23723074
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TRIM8 restores p53 tumour suppressor function by blunting N-MYC activity in chemo-resistant tumours.
    Mastropasqua F; Marzano F; Valletti A; Aiello I; Di Tullio G; Morgano A; Liuni S; Ranieri E; Guerrini L; Gasparre G; Sbisà E; Pesole G; Moschetta A; Caratozzolo MF; Tullo A
    Mol Cancer; 2017 Mar; 16(1):67. PubMed ID: 28327152
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miRNA-144 suppresses proliferation and migration of colorectal cancer cells through GSPT1.
    Xiao R; Li C; Chai B
    Biomed Pharmacother; 2015 Aug; 74():138-44. PubMed ID: 26349975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comprehensive Analysis of miRNome Alterations in Response to Sorafenib Treatment in Colorectal Cancer Cells.
    Pehserl AM; Ress AL; Stanzer S; Resel M; Karbiener M; Stadelmeyer E; Stiegelbauer V; Gerger A; Mayr C; Scheideler M; Hutterer GC; Bauernhofer T; Kiesslich T; Pichler M
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27916938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.